Lung
BO45217
A phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of Divarasib versus Sotorasib or Adagrasib in patients with previously treated KRAS G12C-Positive advanced or metastatic non-small cell Lung Cancer.
Trial overview
Medical Oncology
Non-small cell lung cancer (NSCLC)
Lung & bronchus
III
Registration number: NCT06497556
North Shore
North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia
Clinical trials enquiries
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.